文献速递介入腹部DSA

经验性栓塞治疗急性上消化道动脉出血的Meta分析

Empiric Transcatheter Embolization for Acute Arterial Upper Gastrointestinal Bleeding: A Meta-Analysis.
PubMed 文献 · AJR Am J Roentgenol · 2021-02-10

该Meta分析纳入13项研究(12项回顾性、1项前瞻性),共725例急性上消化道出血患者,其中357例(49.2%)接受经验性栓塞。经验性栓塞临床成功率为74.7%(95%CI 63.1-86.3%),生存率为80.9%(95%CI 73.8-88.0%)。比较研究显示,经验性栓塞与目标性栓塞在再出血率、死亡率及需手术率上均无统计学显著差异。

要点

  • 经验性栓塞临床成功率74.7%,生存率80.9%,与目标性栓塞在再出血和死亡率上无显著差异。
  • 经验性栓塞特异性并发症发生率1.9%,目标性栓塞为2.4%。
  • 对于血管造影阴性的急性上消化道出血,经验性栓塞似乎与目标性栓塞同样有效。

诊断标准与关键数值

  • 经验性栓塞临床成功率74.7%(95%CI 63.1-86.3%),基于13项研究。
  • 经验性栓塞生存率80.9%(95%CI 73.8-88.0%),基于10项研究。
  • 经验性栓塞与目标性栓塞再出血率比较:36.5% vs 29.6%(OR 1.13,95%CI 0.77-1.65,p=.53),基于111项研究,无统计学显著差异。
  • 经验性栓塞与目标性栓塞死亡率比较:23.3% vs 18.0%(OR 1.44,95%CI 0.89-2.33,p=.14),基于8项研究,无统计学显著差异。
  • 经验性栓塞与目标性栓塞需手术控制再出血率比较:17.8% vs 13.4%(OR 1.34,95%CI 0.58-3.07,p=.49),基于4项研究,无统计学显著差异。

局限性

  • 纳入的13项研究中12项为回顾性研究,1项为前瞻性研究。
  • 再出血率比较的原文表述为「111 studies」,原文此处表述有矛盾。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE. The purpose of this study was to conduct a meta-analysis to assess the safety and efficacy of empiric embolization compared with targeted embolization in the treatment of acute upper gastrointestinal bleeding (UGIB). MATERIALS AND METHODS. We searched the PubMed and Cochrane Library databases for studies performed without language restrictions from January 2000 to November 2019. Only clinical studies with a sample size of five or more were included. Clinical success, rebleeding and complication rates, survival rates, bleeding cause, embolic materials, and vessels embolized were recorded. Empiric embolization and targeted embolization (i.e., embolization performed based on angiographic evidence of ongoing bleeding) were compared when possible. Meta-analysis was performed. RESULTS. Among 13 included studies (12 retrospective and 1 prospective), a total of 357 of 725 patients (49.2%) underwent empiric embolization for UGIB. The clinical success rate of empiric embolization was 74.7% (95% CI, 63.1-86.3%) among the 13 studies, and the survival rate was 80.9% (95% CI, 73.8-88.0%) for 10 studies. On the basis of comparative studies, no statistically significant difference was observed between empiric and targeted embolization in terms of rebleeding rate in 111 studies (36.5% vs 29.6%; odds ratio [OR], 1.13; 95% CI, 0.77-1.65; p = .53), mortality in eight studies (23.3% vs 18.0%; OR, 1.44; 95% CI, 0.89-2.33; p = .14), and need for surgery to control rebleeding in four studies (17.8% vs 13.4%; OR, 1.34; 95% CI, 0.58-3.07; p = .49). The pooled embolization-specific complications were 1.9% (empiric) and 2.4% (targeted). CONCLUSION. According to all available published evidence, empiric embolization assessed with endoscopic or preprocedural imaging findings (or both) appears to be as effective as targeted embolization in preventing rebleeding and mortality in patients with angiographically negative acute UGIB. Because of its favorable safety profile, empiric embolization should be considered for patients in this clinical scenario.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Yu Q, Funaki B, Navuluri R, et al. Empiric Transcatheter Embolization for Acute Arterial Upper Gastrointestinal Bleeding: A Meta-Analysis. AJR Am J Roentgenol. 2021. PMID: 33566631. doi:10.2214/AJR.20.23151

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。